NCT00452868View on ClinicalTrials.gov

Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in ChildrenNeurotoxicityPsychosocial Effects of Cancer and Its TreatmentRadiation Toxicity
Interventions
DRUG

Donepezil

Donepezil 5 milligrams a day for 6 weeks

Trial Locations (2)

02111

Tufts-NEMC Cancer Center, Boston

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00452868 - Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain | Biotech Hunter | Biotech Hunter